ScholarIQanswers from OpenAlex & ORCID
David P. Steensma
ResearcherPublications, citations & collaboration network
David P. Steensma is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David P. Steensma have?
ScholarIQindexed works
David P. Steensma has 931 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David P. Steensma have?
ScholarIQcitation count
David P. Steensma has 26,100 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David P. Steensma?
ScholarIQh-index
David P. Steensma has an h-index of 81 in OpenAlex.
What is the i10-index of David P. Steensma?
ScholarIQi10-index
David P. Steensma has an i10-index of 317 in OpenAlex.
What is the ORCID of David P. Steensma?
ScholarIQorcid
The ORCID for David P. Steensma is on the source record.
What is the OpenAlex record for David P. Steensma?
ScholarIQopenalex
The OpenAlex for David P. Steensma is on the source record.
What are the most-cited papers on David P. Steensma?
ScholarIQmost cited works
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou, Amanda L. Christie, Johannes Köster, Tiffany DeSouza, Elizabeth A. Morgan, Scott P. Kallgren, Huiyun Liu, Shuo-Chieh Wu, Olivia D. Plana, Joan Montero, Kristen E. Stevenson, Prakash K. Rao, Raga Vadhi, Michael Andreeff, Philippe Armand, Karen K. Ballen, Patrizia Barzaghi-Rinaudo, Sarah Cahill, Rachael A. Clark, Vesselina G. Cooke, Matthew S. Davids, Daniel J. DeAngelo, David M. Dorfman, Hilary Eaton, Benjamin L. Ebert, Julia Etchin, Brant Firestone, David C. Fisher, Arnold S. Freedman, Ilene Galinsky, Hui Gao, Jacqueline S. Garcia, Francine Garnache‐Ottou, Timothy A. Graubert, Alejandro Gutiérrez, Ensar Halilovic, Marian H. Harris, Zachary T. Herbert, Steven M. Horwitz, Giorgio Inghirami, Andrew M. Intlekofer, Moriko Ito, Shai Izraeli, Eric D. Jacobsen, Caron A. Jacobson, Sébastien Jeay, Irmela Jeremias, Michelle A. Kelliher, Raphael Koch, Marina Konopleva, Nadja Kopp, Steven M. Kornblau, Andrew L. Kung, Thomas S. Kupper, Nicole R. LeBoeuf, Ann S. LaCasce, Emma Lees, Loretta S. Li, A. Thomas Look, Masato Murakami, Markus Müschen, Donna Neuberg, Samuel Y. Ng, Oreofe O. Odejide, Stuart H. Orkin, Rachel R. Paquette, Andrew E. Place, Justine E. Roderick, Jeremy Ryan, Stephen E. Sallan, Brent Shoji, Lewis B. Silverman, Robert J. Soiffer, David P. Steensma, Kimberly Stegmaier, Richard M. Stone, Jérôme Tamburini, Aaron R. Thorner, Paul Van Hummelen, Martha Wadleigh, Marion Wiesmann, Andrew P. Weng, Jens Wuerthner, David A. Williams, Bruce M. Wollison, Andrew A. Lane, Anthony Letai, Monica M. Bertagnolli, Jerome Ritz, Myles Brown, Henry W. Long, Jon C. Aster, Margaret A. Shipp, James D. Griffin, David M. Weinstock
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P. Steensma, Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji, Jay Yang, Andrew M. Brunner, Hetty E. Carraway, Lionel Adès, Aref Al‐Kali, Juan Manuel Alonso‐Domínguez, Ana Alfonso Piérola, Catherine C. Coombs, H. Joachim Deeg, Ian W. Flinn, James M. Foran, Guillermo Garcia‐Manero, Michael B. Maris, Malgorzata McMasters, Jean‐Baptiste Micol, Jaime Pérez de Oteyza, Felicitas Thol, Eunice S. Wang, Justin M. Watts, Justin Taylor, Richard M. Stone, Vikram Gourineni, Alyssa J. Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker
Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia
Areej El‐Jawahri, Gregory A. Abel, David P. Steensma, Thomas W. LeBlanc, Amir T. Fathi, Timothy A. Graubert, Daniel J. DeAngelo, Martha Wadleigh, Karen K. Ballen, Julia Foster, Eyal C. Attar, Philip C. Amrein, Andrew M. Brunner, Richard M. Stone, Jennifer S. Temel